UPDATE : Wednesday, June 19, 2019
상단여백
Six Tamiflu takers suffered abnormalities in 5 years
Six patients who received influenza treatment Tamiflu had neuropsychiatric ...
by Song Soo-youn  |  2019-01-10 14:19
라인
Tego Science releases research results for diabetic foot ulcer treatment
Tego science said Thursday that it has confirmed the superior efficacy resu...
by Lee Han-soo  |  2019-01-10 12:48
라인
MSD Korea recalls HIV drug Stocrin with particular code
MSD Korea said it would recall HIV treatment Stocrin (ingredient: efavirenz...
by Lee Hye-seon  |  2019-01-10 11:46
라인
Pfizer to stop renewing risk-sharing accord for lung cancer drug
Pfizer said it would not renew its risk-sharing agreement (RSA) for Xalkori...
by Lee Han-soo  |  2019-01-10 10:40
라인
Hugel wins patent for patch-type BTX product
Hugel said Wednesday that it has registered a patent for the microstructure...
by Lee Han-soo  |  2019-01-09 16:31
라인
Hanmi to start P1 trial about diabetes combination treatment
Hanmi Pharmaceutical has received approval from the Ministry of Food and Dr...
by Lee Han-soo  |  2019-01-09 14:51
라인
Pharma Research Bio to start P1 clinical trials about BTX
Pharma Research Bio said Monday that it has received approval from the Mini...
by Lee Han-soo  |  2019-01-09 14:51
라인
Regulator keeps Kyung Nam Pharm listed with 1-year grace period
The Korean stock market operator decided to keep Kyung Nam Pharm listed on ...
by Lee Hye-seon  |  2019-01-09 14:49
라인
Anti-Alzheimer drink Souvenaid mired in illegal ad controversy -- again
Handok has illegally promoted Souvenaid, a new drink for mild cognitive imp...
by Lee Min-ju  |  2019-01-08 16:10
라인
Handok and Genexine become largest stakeholder of Rezolute
Korean pharmaceuticals Handok and Genexine said they have jointly become th...
by Lee Hye-seon  |  2019-01-08 14:53
라인
GC, CANbridge ink licensing agreement for Hunter Syndrome drug
GC said Tuesday that it has signed an exclusive licensing agreement in the ...
by Lee Han-soo  |  2019-01-08 12:15
라인
Local firms aim to win rights to sell Vemlidy
Korean drugmakers are seeking to acquire preferential rights to market the ...
by Lee Han-soo  |  2019-01-08 12:14
라인
New influenza drug to be tested in phase-3 trial in Korea
The Korean government has approved a phase-3 clinical trial to evaluate the...
by Lee Hye-seon  |  2019-01-07 15:30
라인
China accepts change in Daewoong’s clinical trial application
Daewoong Pharmaceutical said Monday that the China Food and Drug Administra...
by Lee Han-soo  |  2019-01-07 14:59
라인
Yuhan, Gilead to develop drug against nonalcoholic fatty liver
Yuhan Corp. said Monday that it has signed a licensing and cooperation agre...
by Lee Han-soo  |  2019-01-07 14:00
라인
Regulator to nix approval for Lou Gehrig's drug Yoos Neurosolution
The Korean drug regulator is likely to nullify approval for Yoos Neurosolut...
by Lee Hye-seon  |  2019-01-07 12:46
라인
GSK sales manager leaps to death
A GSK Korea sales manager in charge of consumer healthcare division jumped ...
by Lee Han-soo  |  2019-01-04 14:57
라인
Hyundai Pharm files complaint against Pfizer
Hyundai Pharmaceutical has filed an unfair trade practice complaint against...
by Lee Han-soo  |  2019-01-04 14:57
라인
Pfizer gets larger reimbursement for hemophilia treatments
Pfizer Korea said Thursday that the Ministry of Health and Welfare has appr...
by Lee Han-soo  |  2019-01-03 12:25
라인
Lilly Korea adds indications for ‘Cyramza’ and ‘Taltz’
Lilly Korea said Wednesday that Cyramza (ingredient name: Ramucirumab), its...
by Lee Han-soo  |  2019-01-03 10:49
여백
여백
여백
Back to Top